This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre Hospitalier Régional Universitaire De Lille, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2017.
Company Filing History:
1 out of 26 
1 out of 5,383 
1 out of 1,853 
Years Active: 2017
Title: Monique Capron: Innovator in Autoimmune Disease Treatment
Introduction
Monique Capron is a notable inventor based in Phalempin, France. She has made significant contributions to the field of medical research, particularly in the treatment of inflammatory autoimmune diseases. Her innovative work has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Monique Capron holds a patent for "28 kDa GST proteins from schistosoma for the use thereof in the treatment of inflammatory autoimmune diseases generating a Th1 and/or Th17 response." This invention relates to a product selected from a protein, a fragment of the protein, a derived sequence, and a homologous sequence of the protein. The protein includes or is constituted by the 28 kDa glutathione S-transferase protein from a schistosome, specifically represented by the sequences SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3. This innovation aims to provide therapeutic solutions for inflammatory autoimmune diseases that generate a Th1 and/or Th17 response.
Career Highlights
Throughout her career, Monique Capron has worked with esteemed institutions such as Université Du Droit Et De La Santé De Lille 2 and the Institut National De La Santé Et De La Recherche Médicale. Her dedication to research and innovation has positioned her as a key figure in her field.
Collaborations
Monique has collaborated with notable colleagues, including Mohamed El Nady and Jean-Frederic Colombel. These partnerships have further enhanced her research and contributions to medical science.
Conclusion
Monique Capron's work exemplifies the impact of innovative research in the treatment of autoimmune diseases. Her patent and collaborations reflect her commitment to advancing medical science and improving patient outcomes.